NCT07209371
- Conditions
- IgA Monoclonal Gammopathy of Undetermined Significance
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
IgA Monoclonal Gammopathy of Undetermined Significance
Explore clinical trials studying IgA Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study